iSono Health

San Francisco, United States Founded: 2014 • Age: 12 yrs
Provider of AI-based 3D wearable device for early breast cancer detection

About iSono Health

iSono Health is a Healthcare company based in San Francisco (United States) founded in 2014. Provider of AI-based 3D wearable device for early breast cancer detection. It operates in the Healthcare and Technology sectors. iSono Health has raised $1.96 million across 6 funding rounds from investors including National Science Foundation, Y Combinator and jskinvestments.cz. Its chief executive, as recorded, is Neda Razavi. iSono Health offers products and services including ATUSA Scanner and ATUSA Software Suite. Its focus areas include High Tech, Wearable Technology, Health and Wellness Devices and Women Health. Its legal entity is iSono Health, Inc. Its competitors include Exo, EchoNous and Emagine Solutions Technology; 2 of its 3 listed competitors have raised funding.

Company details

Founded in 2014 and headquartered in San Francisco, United States, iSono Health operates in the health technology sector. An AI-based 3D wearable device known as the ATUSA scanner is developed for early breast cancer detection. Breast volume is captured by the device to enable repeatable ultrasound imaging at the point of care, supporting diagnosis and patient monitoring in clinical settings.

Key Metrics

Products & Services of iSono Health

iSono Health offers a comprehensive portfolio of products and services, including ATUSA Scanner and ATUSA Software Suite.

ATUSA Scanner
Medical Device

Automated 3D breast ultrasound for fast, accurate cancer imaging and monitoring.

ATUSA Software Suite
Software Tool

Provides 3D visualization and analysis for breast ultrasound diagnostics.

Funding Insights of iSono Health

iSono Health has successfully raised a total of $1.96M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.96M
  • Total Rounds 6
  • First Round $120,000

    (Mar 2016)

  • Investors Count 3

All 6 funding rounds of iSono Health with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2025Seed–jskinvestments.cz
–
Dec 2024$1.84MSeed––
–
Sep 2024$1.04MGrant––
Oct 2019$1.48MGrant––
Jul 2017$225,000Grant––
Mar 2016$120,000Seed–Y Combinator
–
Valuation history

3 investors in total: 3 institutional.

Investors in iSono Health

iSono Health has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include National Science Foundation, Y Combinator and jskinvestments.cz.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage startups are accelerated via funding and educational programs.
ycombinator.comMountain View, United States
A government-backed foundation providing seed-stage investments to support small businesses.
1950nsf.govArlington, United States
jskinvestments.cz
Premium access

Investor details for iSono Health

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of iSono Health

10 people are tracked at iSono Health (4 in leadership, 3 in board & advisors, 3 in team).

NameRoleGroup
Neda Razavi
CEOLeadership
Ed Landau
Director, Hardware EngineeringLeadership
Maryam Ziaei
Founder & CEOLeadership
Shadi Saberi
Founder & CTOLeadership
Said Bolorforosh
AdvisorBoard & advisors
Jeff Schlosser
AdvisorBoard & advisors
Narges Baniasadi
AdvisorBoard & advisors
Syed Measam Abbas
Full-Stack Software EngineerTeam
Carl Johnson
Senior Software Verification Test EngineerTeam
Anusuya Mokashi
AdvisorTeam
Premium access

Complete people profiles for iSono Health

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of iSono Health

3 dated milestones of iSono Health across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded iSono Health is founded.
  2. Funding First funding round of $120K.
  3. Funding Latest funding round, Seed,.

Competitors of iSono Health

iSono Health has 3 listed competitors in our database, 2 of them funded. They include Exo, EchoNous and Emagine Solutions Technology.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
exo.inc2015Redwood, United States$463.39M152
Ultrasound images are analyzed via AI-based software provided by Exo.
echonous.com2015Redmond, United States$194.49M97
AI-assisted handheld ultrasound devices are provided for medical diagnostics.
emaginest.com2017Tucson, United States
Provider of pregnancy management app and device for women and healthcare providers
Premium access

Detailed competitors of iSono Health

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of iSono Health

The website of iSono Health (isonohealth.com) receives about 4.2K visits a month.

  • Monthly visits
    4.2K

    ▲ 166.2% vs previous month

Top companies in Oncology

3 companies that operate in the same segment as iSono Health (Oncology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Isono Health

Premium access

Complete news archive for iSono Health

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about iSono Health

iSono Health was founded in 2014 and raised its 1st funding round 2 years after it was founded.

iSono Health is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Neda Razavi is the CEO of iSono Health, as recorded in our data.

iSono Health is a funded company, having raised a total of $1.96M across 6 funding rounds to date. The company's 1st funding round was a Seed of $120K, raised on Mar 2016.

Founded in 2014 and headquartered in San Francisco, United States, iSono Health operates in the health technology sector. An AI-based 3D wearable device known as the ATUSA scanner is developed for early breast cancer detection. Breast volume is captured by the device to enable repeatable ultrasound imaging at the point of care, supporting diagnosis and patient monitoring in clinical settings.

iSono Health's top competitors include Exo, EchoNous and Emagine Solutions Technology.

iSono Health offers ATUSA Scanner and ATUSA Software Suite.

iSono Health has 3 investors. Key investors include National Science Foundation, Y Combinator, and jskinvestments.cz.

iSono Health operates through Isono Health, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available